• Policy, protocol, and order sets for dosing and monitoring • Pharmacists follow patients daily for dosing, monitoring, prevention of adverse events • Pharmacists/nurses provide patient education. • Reversal agents and guidelines
Per policy, these hazardous drugs have special waste requirements.
Generic (Brand)
Waste Requirements
warfarin (Coumadin)
All tablets and packaging ⇒ BLACK BUCKET
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
• Transport (dose is placed inside a plastic sealable bag): Standard
Nursing: Storage / Administration
Exposure Risk: low
• Handling/administration PPE Requirements: via Mouth- Single pair of CX approved gloves via Tube- double CX gloves and gown Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Omnicell
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: Standard
• Special Manipulation for Administration: n/a
Disposal / Spills
• Disposal of Drug Waste: Full- blue bin Trace/packaging- trash
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: n/a
Reason for exemption of USP<800> Containment Requirements: Purchased in final dosage form; packaged as unit dose. Does not require additional manipulation for dispensing.
Anticoagulant / Antiplatelet Stoppage For Procedures
generic (Brand)
Dept.
Procedure Type (hover over entry for examples)
Stop Medication Prior To Procedure Restart after:
warfarin (Coumadin)
Anesthesia
High-risk
5 days Restart after 6 hours
Intermediate-risk
normal INR ( ≤ 1.2) Restart after 6 hours
Low-risk
5 days Restart after 6 hours
Patients with high risk of bleeding (eg, old age, history of bleeding tendency, concurrent uses of other anticoagulants/antiplatelets, liver cirrhosis or advanced liver disease, and advanced renal disease) undergoing low- or intermediate-risk procedures should be treated as intermediate or high risk, respectively.
Radiology
Invasive Procedures
7 days
Paracentesis/Thoracentesis
5 days
Surgery
High-risk
5 days, INR < 1.4 Restart after 12-24 hours
Low-risk
5 days, INR < 1.4 Restart after 12-24 hours
Bridging anticoagulation may be appropriate in patients who will have a very high thromboembolic risk with prolonged interruption of their anticoagulant, such as warfarin.
Enteral Drug Administration notes.
Generic (Brand)
Comments and Considerations
Recommendations for Administration with Enteral Nutrition
warfarin (Jantoven, Coumadin)
Variable Vit-K content, protein binding
Suggest holding tube feeding 1 hour before and 1 hour after administration. Avoid soy protein feeds.
Last updated: May. 22, 2025
Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
• Pharmacists follow patients daily for dosing, monitoring, prevention of adverse events
• Pharmacists/nurses provide patient education.
• Reversal agents and guidelines
The following outlines must be followed.
[Packaging: Manufacturer ⇒ Dispense]
[UD ⇒ UD]
2 mg tablet (IMH)
2.5 mg tablet
5 mg tablet (IMH)
NIOSH Table 2B↑
Receiving / Storage / Preparation
Storage / Administration
via Tube- double CX gloves and gown
Wash hands after handling
Trace/packaging- trash
(hover over entry for examples)
(Coumadin)
(Brand)
(Jantoven, Coumadin)